Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Jørgensen, Anders W ^a   Lundstrøm, Lars H ^a   Wetterslev, Jørn ^a   Astrup, Arne ^b   Gøtzsche, Peter C ^a,c  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOPIRAMATE; ANTIOBESITY AGENT; FRUCTOSE;

ARTICLE; BASELINE CARRIED FORWARD METHOD; BODY WEIGHT; CASE CONTROL STUDY; CLINICAL RESEARCH; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DATA ANALYSIS; DIET THERAPY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESEARCH; HUMAN; IMPUTATION METHOD; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; INTERVENTION STUDY; LAST OBSERVATION CARRIED FORWARD METHOD; MAJOR CLINICAL STUDY; MATHEMATICAL PARAMETERS; MULTIPLE IMPUTATION METHOD; OBESITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; WEIGHT CHANGE; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANTI-OBESITY AGENTS; BODY WEIGHT; DATA INTERPRETATION, STATISTICAL; FRUCTOSE; HUMANS; OBESITY; TREATMENT OUTCOME;

EID: 84912074150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111964     Document Type: Article

References (23)

1. Fabricatore AN, Wadden TA, Moore RH, Butryn ML, Gravallese EA, et al. (2009) Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis. Obes Rev 10: 333-341.
2. Elobeid MA, Padilla MA, McVie T, Thomas O, Brock DW, et al. (2009) Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods. PLoS ONE 4: e6624.
3. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, et al. (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338: b2393.
4. Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM (2006) Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 5: 1087-1091.
5. Methods for voluntary weight loss and control (1992) NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992. Ann Intern Med 1993; 119: 764-770.
6. Ware JH (2003) Interpreting incomplete data in studies of diet and weight loss. NEJM 348: 2136-2137.
7. Beunckens C, Molenberghs G, Kenward MG (2005) Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials. Clin Trials 2: 379-386.
8. Molenberghs G, Kenward M (2007) Missing data in clinical studies. Wiley.
9. Gadbury GL, Coffey CS, Allison DB (2003) Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF. Obes Rev 4: 175-184.
10. Astrup A, Caterson I, Zelissen P, Guy-Grand B, Carruba M, et al. (2004) Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 12: 1658-1669.
11. Little RJA (1988) A Test of Missing Completely at Random for Multivariate Data with Missing Values. Journal of the American Statistical Association. 83: 1198-1202.
12. PASW Missing Values 18. http://support.spss.com/productsext/statistics/documentation/18/client/User%20Manuals/English/PASW%20Missing%20Values%2018.pdf. Accessed 14 Feb 2011.
13. Kramer CK, Leitão CB, Pinto LC, Canani LH, Azevedo MJ, et al. (2011) Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials. Obes Rev 12: e338-347.
14. Sinharay S, Stern HS, Russell D (2001) The use of multiple imputation for the analysis of missing data. Psychol Methods 6: 317-329.
15. Schafer JL, Graham JW (2002) Missing data: Our view of the state of the art. Psychological Methods7: 147-177.
16. Schafer JL (1999) Multiple imputation: a primer. Stat Methods Med Res 8: 3-15.
17. Carpenter J, Kenward M Missing data in randomised controlled trials-a practical guide. http://www.haps.bham.ac.uk/publichealth/methodology/docs/invitations/Final-Report-RM04-JH17-mk.pdf. Accessed 14 Feb 2011.
18. Simons-Morton DG, Obarzanek E, Cutler JA (2006) Obesity research-limitations of methods, measurements, and medications. JAMA 295: 826-828.
19. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295: 761-775.
20. Rock CL, Flatt SW, Sherwood NE, Karanja N, Pakiz B, et al. (2010) Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: a randomized controlled trial. JAMA 304: 1803-1810.
21. Smith IG, Goulder MA (2001) Randomized placebo-controlled trial of longterm treatment with sibutramine in mild to moderate obesity. J Fam Pract 50: 505-512.
22. Gorber SC, Tremblay M, Moher D, Gorber B (2007) A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 8: 307-26.
23. Guideline on Missing Data in Confirmatory Clinical Trials (2010) 10 July 2010. http://www.ema.europa.eu/ema/pages/includes/document/open-document.jsp?webContentId=WC500096793. Accessed 9 Nov 2012.